[Modern views on rheumatic fever].
Submitted in the paper are modern conceptions on etiology, pathophysiology, diagnosis and treatment of acute inflammatory rheumatism (IR). Some aspects of IR course in different age groups are highlighted, high informative value of new laboratory methods of diagnosis of its latent forms are validated. The place of interferons and selective inhibitors of COG-2 in the treatment of IR is determined.
Dudka
P F
PF
Sakharchuk
I I
II
Il'nyts'kyĭ
P I
PI
Lukasevych
L M
LM
Tarchenko
I P
IP
Bondarenko
Iu M
IuM
Mykhaĭlevs'ka
T V
TV
D000293:Adolescent; D000328:Adult; D051546:Cyclooxygenase 2; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use*; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use*; D007527:Isoenzymes / Q000037:antagonists & inhibitors; D008565:Membrane Proteins; D011451:Prostaglandin-Endoperoxide Synthases; D011994:Recombinant Proteins; D012213:Rheumatic Fever / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D012214:Rheumatic Heart Disease / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology
D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors; D007370:Interferon Type I; D007527:Isoenzymes; D008565:Membrane Proteins; D011994:Recombinant Proteins; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D011451:Prostaglandin-Endoperoxide Synthases